UNLIMITED TURBO LONG - NOVARTIS N Share Price

Certificat

DE000PX2CAC1

Delayed Deutsche Boerse AG 15:21:00 22/05/2024 BST
4.63 EUR -1.28% Intraday chart for UNLIMITED TURBO LONG - NOVARTIS N
Current month+7.93%
1 month+13.20%
Date Price Change
22/05/24 4.63 -1.28%
21/05/24 4.69 +0.43%
17/05/24 4.67 +0.86%
16/05/24 4.63 -1.49%
15/05/24 4.7 0.00%

Delayed Quote Deutsche Boerse AG

Last update May 22, 2024 at 03:21 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PX2CAC
ISINDE000PX2CAC1
Date issued 29/07/2019
Strike 54.02 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 3.5
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 4.77
Lowest since issue 1.25

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
101.9 USD
Average target price
108 USD
Spread / Average Target
+5.92%
Consensus